Outcomes and computed tomography scan follow-up of bioresorbable vascular scaffold for the percutaneous treatment of chronic total coronary artery occlusion

American Journal of Cardiology

Volumn 115, Issue 11, 2015, Pages 1487-1493

  Ojeda, Soledad ^a   Pan, Manuel ^a   Romero, Miguel ^a   Suárez De Lezo, Javier ^a   Mazuelos, Francisco ^a   Segura, José ^a   Espejo, Simona ^a   Morenate, Carmen ^a   Blanco, Marta ^a   Martín, Pedro ^b   Medina, Alfonso ^b   Suárez De Lezo, José ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; TICAGRELOR;

ADULT; ARTICLE; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; CHRONIC TOTAL CORONARY ARTERY OCCLUSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DISEASE DURATION; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; VASCULAR GUIDE WIRE; AGED; BIODEGRADABLE IMPLANT; CHRONIC DISEASE; CORONARY OCCLUSION; EVALUATION STUDY; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; TISSUE SCAFFOLD; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; CHRONIC DISEASE; CORONARY OCCLUSION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84929262728     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.048     Document Type: Article

References (24)

1. M. Kimura, O. Katoh, E. Tsuchikane, K. Nasu, Y. Kinoshita, M. Ehara, M. Terashima, H. Matsuo, T. Matsubara, K. Asakura, Y. Asakura, S. Nakamura, A. Oida, S. Takase, N. Reifart, C. Di Mario, and T. Suzuki The efficacy of a bilateral approach for treating lesions with chronic total occlusions the CART (controlled antegrade and retrograde subintimal tracking) registry JACC Cardiovasc Interv 2 2009 1135 1141
2. G. Sianos, G.S. Werner, A.R. Galassi, M.I. Papafaklis, J. Escaned, D. Hildick-Smith, E.H. Christiansen, A. Gershlick, M. Carlino, A. Karlas, N.V. Konstantinidis, S.D. Tomasello, C. Di Mario, N. Reifart EuroCTO Club Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club EuroIntervention 8 2012 139 145
3. M. Yamane, M. Muto, T. Matsubara, S. Nakamura, T. Muramatsu, A. Oida, Y. Igarashi, Y. Nozaki, M. Kijima, and E. Tuschikane Contemporary retrograde approach for the recanalisation of coronary chronic total occlusion: on behalf of the Japanese Retrograde Summit Group Eurointervention 9 2013 102 109
4. S. Shirai, T. Kimura, M. Nobuyoshi, T. Morimoto, K. Ando, Y. Soga, K. Yamaji, K. Kondo, K. Sakai, T. Arita, M. Goya, M. Iwabuchi, H. Yokoi, H. Nosaka, K. Mitsudo for the j-Cypher Registry Investigators Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher registry JACC Cardiovasc Interv 3 2010 180 188
5. S.S. Naidu, M.W. Krucoff, D.R. Rutledge, V.W. Mao, W. Zhao, Q. Zheng, O. Wilburn, K. Sudhir, C. Simonton, and J.B. Hermiller Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation results from the 8,061-Patient XIENCE V United States study JACC Cardiovasc Interv 5 2012 626 635
6. Y. Onuma, and P.W. Serruys Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 123 2011 779 797
7. Y. Morino, M. Abe, T. Morimoto, T. Kimura, Y. Hayashi, T. Muramatsu, M. Ochiai, Y. Noguchi, K. Kato, Y. Shibata, Y. Hiasa, O. Doi, T. Yamashita, T. Hinohara, H. Tanaka, K. Mitsudo for the J-CTO Registry Investigators Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. The j-CTO (Multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool JACC Cardiovasc Interv 4 2011 213 221
8. I.D. Moussa, LlW. Klein, B. Shah, R. Mehran, M.J. Mack, E.S. Brilakis, J.P. Reilly, G. Zoghbi, E. Holper, and G.W. Stone Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI) J Am Coll Cardiol 62 2013 1563 1570
9. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys on behalf of the Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
10. Y. Onuma, D. Dudek, L. Thuesen, M. Webster, K. Nieman, H.M. Garcia-Garcia, J.A. Ormiston, and P.W. Serruys Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease. The ABSORB Cohort a trial JACC Cardiovasc Interv 6 2013 999 1009
11. A. Abizaid, J.R. Costa Jr., A.L. Bartorelli, R. Whitbourn, R.J. van Geuns, B. Chevalier, T. Patel, A. Seth, M. Stuteville, C. Dorange, W.F. Cheong, K. Sudhir, and P.W. Serruys The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled Eurointervention 2014 pii: 20130827-06
12. P.W. Serruys, B. Chevalier, D. Dudek, A. Cequier, D. Carrié, A. Iñiguez, M. Dominici, R.J. van der Schaaf, M. Haude, L. Wasungu, S. Veldhof, L. Peng, P. Staehr, M.J. Grundeken, Y. Ishibashi, H.M. García-García, and Y. Onuma A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
13. J. Iqbal, Y. Onuma, J. Ormiston, A. Abizaid, R. Waksman, and P. Serruys Bioresorbable scaffolds: rationale, current status, challenges, and future Eur Heart J 35 2014 765 776
14. J. Gomez-Lara, L. Teruel, S. Homs, J.L. Ferreiro, R. Romaguera, G. Roura, G. Sánchez-Elvira, F. Jara, S. Brugaletta, J.A. Gomez-Hospital, and Angel Cequier Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up Eurointervention 9 2014 1181 1188
15. R. Valenti, R. Vergara, A. Migliorini, G. Parodi, N. Carrabba, G. Cerisano, E.V. Dovellini, and D. Antoniucci Predictors of reocclusion after successful drug-eluting stent-supported percutaneous coronary intervention of chronic total occlusion J Am Coll Cardiol 61 2013 545 550
16. S. Basavarajaiah, T. Naganuma, A. Latib, T. Hasegawa, A. Sharp, A. Rezq, A. Sticchi, F. Figini, A. Amato, and A. Colombo Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stents Catheter Cardiovasc Interv 84 2014 1042 1050
17. H.J. Colmenarez, J. Escaned, C. Fernández, L. Lobo, S. Cano, J.G. del Angel, F. Alfonso, P. Jimenez, C. Bañuelos, N. Gonzalo, E. Garccía, R. Hernández, and C. Macaya Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis J Am Coll Cardiol 55 2010 1854 1866
18. M. Almalla, V. Hennings, N. Marx, and R. Hoffmann Long-term clinical and angiographic outcome after treatment of chronic total occlusion with everolimus or sirolimus eluting stents Int J Cardiol 157 2012 451 452
19. H.J. Park, H.Y. Kim, J.M. Lee, Y.S. Choi, C.S. Park, D.B. Kim, S.H. Her, Y.S. Koh, M.W. Park, B.J. Kwon, P.J. Kim, K. Chang, W.S. Chung, and K.B. Seung Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion - CAtholic Total Occlusion Study (CATOS) trial Circ J 76 2012 868 875
20. J. Wohrle, W. Rottbauer, and A. Imhof Everolimus-eluting stents for treatment of chronic total coronary occlusions Clin Res Cardiol 101 2012 23 28
21. R. Moreno, E. García, R. Teles, J.R. Rumoroso, H. Cyrne Carvalho, F.J. Goicolea, J. Moreu, J. Mauri, M. Sabaté, V. Mainar, L. Patricio, M. Valdés, F. Fernández Vázquez, A. Sánchez-Recalde, G. Galeote, S. Jimenez-Valero, M. Almeida, E. Lopez de Sa, L. Calvo, I. Plaza, J.L. Lopez-Sendón, J.L. Martín CIBELES Investigators Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial Circ Cardiovasc Interv 6 2013 21 28
22. K. Gert van Houwelingen, H. Sen, M.K. Lam, K. Tandjung, M.M. Löwik, F.H. de Man, J.H. Louwerenburg, M.G. Stoel, M. Hartmann, G.C. Linssen, C.J. Doggen, and C. von Birgelen Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial Catheter Cardiovasc Interv 85 2015 E76 E82
23. J. Wiebe, C. Liebetrau, O. Dörr, A. Most, K. Weipert, J. Rixe, T. Bauer, H. Möllmann, A. Elsässer, C.W. Hamm, and H.M. Nef Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion Int J Cardiol 179 2015 90 94
24. B. Vaquerizo, A. Barros, S. Pujadas, E. Bajo, D. Estrada, F. Miranda-Guardiola, J. Rigla, M. Jiménez, J. Cinca, and A. Serra Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study EuroIntervention 2014 pii: 20140601-04 http://dx.doi.org/10.4244/EIJY14M12-07